Article
Investigation of the impact of an ADCY2 polymorphism as a predictive biomarker in bipolar disorder, suicide tendency and response to lithium carbonate therapy: the first report from Iran.
Pharmacogenomics - 1 Sept 2020
Aghabozorg Afjeh Sara Sadat, Shams Jamal, Hamednia Safar, Boshehri Behzad, Olfat Amir, Omrani Mir Davood
Abstract excerpt
High rates of mortality due to both suicide and medical comorbidities in bipolar patients can be decreased through the administration of lithium, which affects the cerebral endothelium as well as neurons. To investigate the role of ADCY2 in risk of bipolar disorder, we genotyped the ADCY2 rs2290910 in bipolar patients and healthy controls using amplification refractory mutation system PCR. This polymorphism was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
